Clinical Trial: NCT03999710
Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer
Status:
COMPLETEDPhase:
Phase 2| Lead Sponsor: | Memorial Sloan Kettering Cancer Center |
| Information Provided By: | Memorial Sloan Kettering Cancer Center |
| Last Update Posted: | 2026-10-28 |
Study Overview
Brief Summary
The purpose of this study is to see if Durvalumab and radiation therapy can delay the worsening of disease in patients with non-small cell lung cancer normally treated with sequential chemotherapy followed by radiation therapy.
Official Title
Durvalumab With Thoracic Radiation Therapy Without Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (DART)
Conditions
Non Small Cell Lung Cancer, Lung Cancer, Nsclc, NSCLC Stage II, NSCLC, Stage III
Intervention / Treatment
- Radiation: Radiation Therapy
- Drug: Durvalumab
Other Study ID Numbers
- 19-218
Start Date (Actual)
2019-07-19
Primary Completion Date (Actual)
2026-10-20
Study Completion Date (Actual)
2026-10-20
Enrollment (Actual)
61
Study Type
Interventional
Phase
Phase 2
| Lead Sponsor: | Memorial Sloan Kettering Cancer Center |
| Information Provided By: | Memorial Sloan Kettering Cancer Center |
| Last Update Posted: | 2026-10-28 |
Study Overview
Brief Summary
The purpose of this study is to see if Durvalumab and radiation therapy can delay the worsening of disease in patients with non-small cell lung cancer normally treated with sequential chemotherapy followed by radiation therapy.
Official Title
Durvalumab With Thoracic Radiation Therapy Without Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (DART)
Conditions
Non Small Cell Lung Cancer, Lung Cancer, Nsclc, NSCLC Stage II, NSCLC, Stage III
Intervention / Treatment
- Radiation: Radiation Therapy
- Drug: Durvalumab
Other Study ID Numbers
- 19-218
Start Date (Actual)
2019-07-19
Primary Completion Date (Actual)
2026-10-20
Study Completion Date (Actual)
2026-10-20
Enrollment (Actual)
61
Study Type
Interventional
Phase
Phase 2